Exponent (EXPO) Competitors

Exponent currently has a consensus price target of $81.00, suggesting a potential upside of 13.24%. Booz Allen Hamilton has a consensus price target of $84.08, suggesting a potential upside of 11.55%. Given Exponent's stronger consensus rating and higher probable upside, research analysts plainly believe Exponent is more favorable than Booz Allen Hamilton.

Booz Allen Hamilton has higher revenue and earnings than Exponent. Booz Allen Hamilton is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Exponent has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market. Comparatively, Booz Allen Hamilton has a beta of 0.34, suggesting that its stock price is 66% less volatile than the broader market.

In the previous week, Exponent had 9 more articles in the media than Booz Allen Hamilton. MarketBeat recorded 13 mentions for Exponent and 4 mentions for Booz Allen Hamilton. Exponent's average media sentiment score of 1.07 beat Booz Allen Hamilton's score of 0.38 indicating that Exponent is being referred to more favorably in the media.

Exponent has a net margin of 17.67% compared to Booz Allen Hamilton's net margin of 7.01%. Booz Allen Hamilton's return on equity of 76.71% beat Exponent's return on equity.

92.4% of Exponent shares are held by institutional investors. Comparatively, 91.8% of Booz Allen Hamilton shares are held by institutional investors. 1.7% of Exponent shares are held by insiders. Comparatively, 1.1% of Booz Allen Hamilton shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Exponent pays an annual dividend of $1.24 per share and has a dividend yield of 1.7%. Booz Allen Hamilton pays an annual dividend of $2.36 per share and has a dividend yield of 3.1%. Exponent pays out 55.6% of its earnings in the form of a dividend. Booz Allen Hamilton pays out 37.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Exponent has raised its dividend for 12 consecutive years and Booz Allen Hamilton has raised its dividend for 14 consecutive years. Booz Allen Hamilton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Exponent has higher revenue and earnings than Planet Labs PBC. Planet Labs PBC is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

In the previous week, Exponent had 5 more articles in the media than Planet Labs PBC. MarketBeat recorded 13 mentions for Exponent and 8 mentions for Planet Labs PBC. Exponent's average media sentiment score of 1.07 beat Planet Labs PBC's score of 0.56 indicating that Exponent is being referred to more favorably in the media.

Exponent has a net margin of 17.67% compared to Planet Labs PBC's net margin of -111.17%. Exponent's return on equity of 31.48% beat Planet Labs PBC's return on equity.

Exponent currently has a consensus target price of $81.00, suggesting a potential upside of 13.24%. Planet Labs PBC has a consensus target price of $35.36, suggesting a potential upside of 76.62%. Given Planet Labs PBC's higher possible upside, analysts plainly believe Planet Labs PBC is more favorable than Exponent.

92.4% of Exponent shares are held by institutional investors. Comparatively, 41.7% of Planet Labs PBC shares are held by institutional investors. 1.7% of Exponent shares are held by company insiders. Comparatively, 16.4% of Planet Labs PBC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Exponent has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market. Comparatively, Planet Labs PBC has a beta of 2.11, indicating that its stock price is 111% more volatile than the broader market.

Exponent has higher earnings, but lower revenue than Andersen Group. Andersen Group is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

92.4% of Exponent shares are held by institutional investors. 1.7% of Exponent shares are held by insiders. Comparatively, 13.0% of Andersen Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Exponent currently has a consensus price target of $81.00, suggesting a potential upside of 13.24%. Andersen Group has a consensus price target of $52.17, suggesting a potential downside of 6.80%. Given Exponent's higher possible upside, analysts clearly believe Exponent is more favorable than Andersen Group.

In the previous week, Exponent had 11 more articles in the media than Andersen Group. MarketBeat recorded 13 mentions for Exponent and 2 mentions for Andersen Group. Exponent's average media sentiment score of 1.07 beat Andersen Group's score of 0.51 indicating that Exponent is being referred to more favorably in the media.

Exponent has a net margin of 17.67% compared to Andersen Group's net margin of 0.00%. Exponent's return on equity of 31.48% beat Andersen Group's return on equity.

Science Applications International pays an annual dividend of $1.48 per share and has a dividend yield of 1.2%. Exponent pays an annual dividend of $1.24 per share and has a dividend yield of 1.7%. Science Applications International pays out 16.7% of its earnings in the form of a dividend. Exponent pays out 55.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Exponent has raised its dividend for 12 consecutive years. Exponent is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Science Applications International had 2 more articles in the media than Exponent. MarketBeat recorded 15 mentions for Science Applications International and 13 mentions for Exponent. Exponent's average media sentiment score of 1.07 beat Science Applications International's score of 0.63 indicating that Exponent is being referred to more favorably in the news media.

Science Applications International has higher revenue and earnings than Exponent. Science Applications International is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Exponent has a net margin of 17.67% compared to Science Applications International's net margin of 5.55%. Science Applications International's return on equity of 36.96% beat Exponent's return on equity.

Science Applications International has a beta of 0.28, meaning that its stock price is 72% less volatile than the broader market. Comparatively, Exponent has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market.

76.0% of Science Applications International shares are owned by institutional investors. Comparatively, 92.4% of Exponent shares are owned by institutional investors. 0.7% of Science Applications International shares are owned by company insiders. Comparatively, 1.7% of Exponent shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Science Applications International currently has a consensus price target of $116.89, suggesting a potential downside of 7.20%. Exponent has a consensus price target of $81.00, suggesting a potential upside of 13.24%. Given Exponent's stronger consensus rating and higher possible upside, analysts clearly believe Exponent is more favorable than Science Applications International.